• LAST PRICE
    33.0000
  • TODAY'S CHANGE (%)
    Trending Up3.8800 (13.3242%)
  • Bid / Lots
    32.0000/ 2
  • Ask / Lots
    0.0000/ 0
  • Open / Previous Close
    29.5100 / 29.1200
  • Day Range
    Low 29.1200
    High 33.1400
  • 52 Week Range
    Low 19.2300
    High 68.7500
  • Volume
    333,673
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 29.12
TimeVolumeMORF
09:32 ET443129.8
09:39 ET180630.2
09:41 ET83030.49
09:45 ET41230.39
09:48 ET10030.42
09:50 ET10030.38
09:54 ET150030.49
09:56 ET80730.74
09:57 ET80030.735
09:59 ET230030.7
10:01 ET50030.64
10:06 ET80030.755
10:08 ET426430.94
10:10 ET40030.92
10:12 ET10030.92
10:14 ET240030.98
10:15 ET150030.96
10:17 ET30030.96
10:19 ET342431.33
10:21 ET80031.58
10:26 ET50031.54
10:28 ET260931.5
10:30 ET20031.495
10:32 ET30031.58
10:33 ET90031.745
10:35 ET40031.78
10:37 ET10031.88
10:39 ET399131.88
10:42 ET10031.88
10:44 ET77731.65
10:46 ET25031.665
10:48 ET384831.665
10:50 ET20031.665
10:51 ET20031.61
10:53 ET140031.65
10:57 ET20031.65
11:00 ET40031.64
11:04 ET160031.66
11:06 ET170031.65
11:08 ET60031.53
11:09 ET20031.49
11:11 ET30031.52
11:15 ET344931.65
11:18 ET190031.81
11:20 ET35631.92
11:22 ET20032.18
11:26 ET80032.28
11:27 ET20032.25
11:29 ET60032.16
11:31 ET70032.35
11:36 ET20032.42
11:38 ET20032.525
11:40 ET40032.39
11:42 ET30032.29
11:44 ET40332.21
11:51 ET40032.3
11:54 ET158732.43
11:56 ET30032.22
11:58 ET30032.19
12:00 ET20032.08
12:03 ET30032.09
12:07 ET10032.19
12:09 ET30032.175
12:12 ET20032.22
12:14 ET50032.35
12:16 ET60532.215
12:18 ET10032.33
12:21 ET10032.365
12:23 ET40032.37
12:25 ET10032.37
12:27 ET40032.43
12:30 ET20032.435
12:32 ET40032.38
12:36 ET10032.41
12:38 ET20032.36
12:39 ET60032.34
12:43 ET120032.29
12:50 ET130032.24
12:54 ET20032.18
12:56 ET10032.23
01:01 ET80032.18
01:03 ET40032.17
01:06 ET20032.17
01:10 ET149932.175
01:12 ET20032.15
01:15 ET60032.19
01:17 ET20032.15
01:19 ET20032.18
01:21 ET145132.21
01:24 ET30032.17
01:26 ET30032.15
01:32 ET10032.185
01:33 ET10032.19
01:37 ET10032.195
01:42 ET10032.2
01:44 ET10032.16
01:46 ET254332.29
01:51 ET70032.47
01:53 ET30032.44
01:55 ET20032.435
01:57 ET22732.44
02:00 ET30032.425
02:04 ET40032.44
02:08 ET210932.36
02:11 ET60032.46
02:13 ET10032.46
02:15 ET10032.46
02:18 ET20032.46
02:20 ET10032.42
02:24 ET50032.53
02:26 ET10032.515
02:27 ET50032.51
02:29 ET10032.51
02:31 ET20032.565
02:33 ET70032.61
02:36 ET110032.65
02:38 ET30032.67
02:40 ET50032.78
02:42 ET21232.69
02:45 ET90032.8
02:47 ET10032.829
02:49 ET60032.89
02:51 ET90032.915
02:54 ET20032.81
02:56 ET46532.805
02:58 ET20032.805
03:00 ET50032.78
03:02 ET30032.75
03:03 ET10032.75
03:05 ET32032.7597
03:07 ET50032.76
03:09 ET10032.75
03:12 ET40032.73
03:14 ET101732.75
03:16 ET30032.77
03:18 ET30032.82
03:20 ET20032.81
03:21 ET70432.82
03:23 ET10032.77
03:27 ET20032.81
03:30 ET134532.8
03:32 ET80032.745
03:34 ET60332.81
03:36 ET10032.82
03:38 ET832233.04
03:39 ET140032.97
03:41 ET40032.88
03:43 ET20032.95
03:45 ET166732.91
03:48 ET240032.84
03:50 ET90032.79
03:52 ET251632.88
03:54 ET300032.905
03:56 ET411833
03:57 ET359933.08
03:59 ET9283133
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesMORF
Morphic Holding Inc
1.3B
-23.0x
---
United StatesACRS
Aclaris Therapeutics Inc
1.1B
-12.6x
---
United StatesEDIT
Editas Medicine Inc
1.3B
-7.0x
---
United StatesRYTM
Rhythm Pharmaceuticals Inc
1.1B
-6.2x
---
United StatesDSGN
Design Therapeutics Inc
1.3B
-27.3x
---
United StatesERAS
Erasca Inc
1.2B
-7.7x
---
As of 2022-08-14

Company Information

Morphic Holding, Inc. is a biopharmaceutical company. The Company is engaged in discovering and developing a pipeline of oral small molecule integrin therapeutics for the treatment of serious chronic diseases, including autoimmune, cardiovascular and metabolic diseases, fibrosis and cancer. The Company's Morphic integrin technology platform (MInT Platform) helps to develop novel product candidates designed to achieve the potency, high selectivity, and pharmaceutical properties required for oral administration. The Company is advancing its pipeline, including its lead product candidate, MORF-057, which is an α4β7-specific integrin inhibitor affecting inflammation, into clinical development for the treatment of inflammatory bowel disease (IBD). It has also developed selective oral αvβ6-specific integrin inhibitors for the treatment of fibrotic diseases, including idiopathic pulmonary fibrosis. Its subsidiary includes Morphic Therapeutic, Inc., which is a biopharmaceutical company.

Contact Information

Headquarters
35 Gatehouse Dr # A2WALTHAM, MA, United States 02451-1215
Phone
978-729-6480
Fax
302-655-5049

Executives

Independent Chairman of the Board
Gustav Christensen
President, Chief Executive Officer, Director
Praveen Tipirneni
Chief Financial Officer, Chief Operating Officer
Marc Schegerin
Senior Vice President - Finance, Chief Accounting Officer
Robert Farrell
Chief Scientific Officer
Bruce Rogers

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.3B
Revenue (TTM)
$75.3M
Shares Outstanding
38.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.43
Book Value
$9.08
P/E Ratio
-23.0x
Price/Sales (TTM)
17.1
Price/Cash Flow (TTM)
---
Operating Margin
-69.04%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.